This inventor holds 1 USPTO granted patent. Top assignee: Ayerst, Mckenna & Harrison, Inc.. Active years: 1981.
Company Filing History:
Years Active: 1981
Title: The Innovations of Nedumparampil A Abraham
Introduction: Nedumparampil A Abraham is a notable inventor based in Dollard des Ormeaux, Canada. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic peptides. His work focuses on innovative solutions for medical conditions, showcasing his expertise and dedication to improving health outcomes.
Latest Patents: Abraham holds a patent for "Carba decapeptide derivatives of [TYR.sup.6 ]-somatostatin." This patent describes peptides of formula I, where X can be (CH.sub.2).sub.2, S--CH.sub.2, or CH.sub.2--S, or a therapeutically acceptable acid addition salt thereof. These peptides are particularly useful as agents for the treatment of acromegaly and the management of diabetes in mammals. The patent also includes compositions and methods for the preparation of these peptides, highlighting their potential therapeutic applications.
Career Highlights: Abraham is associated with Ayerst, McKenna & Harrison, Inc., where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of peptide-based therapies. With a focus on innovative medical solutions, he continues to push the boundaries of biochemistry.
Collaborations: Throughout his career, Abraham has collaborated with esteemed colleagues, including Francesco Bellini and Hans U Immer. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion: Nedumparampil A Abraham's contributions to the field of biochemistry and his innovative patent for therapeutic peptides underscore his role as a significant inventor. His work not only addresses critical health issues but also exemplifies the impact of scientific research on medical advancements.